Drug Trial Radar · NCT07060989
A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation
Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
220
Planned (sponsor's estimate)
Start
Aug 4, 2025
Primary completion
Dec 2028
Study completion Dec 2029
Sponsor
- Lead sponsor
- Nutshell Therapeutics (Shanghai) Co., LTD.Industry
- Sponsor type
- Industry
- First posted
- Jul 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to evaluate the safety, tolerability, PK, and preliminary efficacy of NTS071 in adults with TP53 Y220C-mutated solid tumors.
Conditions
- Advanced Solid Tumors
Interventions
NTS071Drug
Oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1: Number of dose-limiting toxicity (DLT)Time frame: The first 26 days of treatment (Cycle 1) per patient
- Phase 1: incidence of adverse events (AE), serious adverse events (SAEs)Time frame: up to 30 days after the last administration
- Phase 2a: Overall Response Rate (ORR)Time frame: Up to 3 years
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
Yale Cancer Center
New Haven, Connecticut · Recruiting
University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
NEXT Virginia
Fairfax, Virginia · Recruiting
Peking University People's Hospital
Beijing, China · Recruiting
Beijing Cancer Hospital
Beijing, China · Recruiting
Guangdong Provincial People's Hospital
Guangzhou, China · Not yet recruiting
The First Affiliated Hospital of Nanchang University - Xianghu District
Nanchang, China · Recruiting
Fudan University Shanghai Cancer Center
Shanghai, China · Recruiting
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China · Recruiting
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.